[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100467336":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":40,"centralContacts":41,"locations":50,"responsibleParty":68,"collaborators":71,"id":75,"slug":40,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":40,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":40,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":40,"overallStatus":53,"whyStopped":40,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Seoul National University Bundang Hospital","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Atmeg with Omethyl Cutielet","EXPERIMENTAL","Atmeg: 2 capsules daily (1 capsule containes atorvastatin 10 mg and Omega-3 1000 mg) Omethyl Cutielet: Omega-3 2000mg (920mg as EPA ethyl ester, 760mg as DHA ethyl ester) once daily",[13],"Drug: Omega 3-Atorvastatin",{"label":15,"type":16,"description":17,"interventionNames":18},"Atmeg","ACTIVE_COMPARATOR","Atmeg: 2 capsules daily (1 capsule containes atorvastatin 10 mg and Omega-3 1000 mg)",[13],{"label":20,"type":16,"description":21,"interventionNames":22},"ezetimibe\u002Fatorvastatin 10\u002F20","1 tablet once daily (atorvastatin 20mg with ezetimibe 10mg)",[23],"Drug: Atorvastatin-Ezetimibe",[25,32,36],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","Omega 3-Atorvastatin","Atmeg 2 capsules with 1 pack of Omethyl cutielet",[9],[31],"Atmeg-Omethyl cutielet",{"type":26,"name":27,"description":33,"armGroupLabels":34,"otherNames":35},"Atmeg 2 capsules",[15],[15],{"type":26,"name":37,"description":38,"armGroupLabels":39,"otherNames":40},"Atorvastatin-Ezetimibe","ezetimibe\u002Fatorvastatin 10\u002F20 mg",[20],null,[42,47],{"name":43,"role":44,"phone":45,"phoneExt":40,"email":46},"Soo Lim","CONTACT","+82-31-787-7035","limsoo@snu.ac.kr",{"name":48,"role":44,"phone":40,"phoneExt":40,"email":49},"Minji Sohn","rainbowmjs@naver.com",[51],{"facility":52,"status":53,"city":54,"state":55,"zip":56,"country":57,"countryCode":40,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"SNUBH","RECRUITING","Seongnam-si","Gyeonggi-do","13620","South Korea",{"type":59,"coordinates":60},"Point",[61,62],127.13778,37.43861,{"lat":62,"lon":61},[65],{"name":66,"role":44,"phone":67,"phoneExt":40,"email":46},"Soo Lim, MD, PHD","01097662706",{"type":69,"investigatorFullName":43,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":40,"oldOrganization":40},"PRINCIPAL_INVESTIGATOR","Professor",[72],{"name":73,"class":74},"Korea United Pharm. Inc.","INDUSTRY","100467336",false,"NCT05365438","Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia","Effect of Atorvastatin and Omega 3 Combination Therapy on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes and Combined Dyslipidemia","Inclusion Criteria:\n\n* Type 2 diabetes under treatment with HbA1c 6.0-10.0% at screening visit\n* Male or female of 20 years or over\n* Mixed dyslipidemia under moderate-intensity statin: triglyceride ≥200 mg\u002FdL, HDL-cholesterol ≤50 mg\u002FdL, LDL-cholesterol ≥100 mg\u002FdL\n\n  * moderate-intensity statin: atorvastatin 10-20mg, rosuvastatin 5mg, simvastatin 20-40mg, pravastatin 40-80mg, lovastatin 40mg, fluvastatin XL 80mg, fluvastatin 40mg bid, pitavastatin 2-4mg\n* Identified carotid artery plaque: carotid intima-media thickness (cIMT) ≥ 1.0 mm\n* Asymptomatic patients without history of angina, myocardial infarction, or cerebral infarction\n* Creatinine ≤1.8 mg\u002FdL\n\nExclusion Criteria:\n\n* Dyslipidemia which requires other therapy: triglyceride ≥500 mg\u002FdL or LDL-cholesterol ≥190 mg\u002FdL\n* Uncontrolled hypertension: SBP \\>180 mmHg or DBP \\>110 mmHg\n* Severe renal dysfunction: eGFR \\\u003C30 mL\u002Fmin\u002F1.73m2\n* AST\u002FALT \\>120\u002F120 or chronic liver disease\n* Pregnant or childbearing woman who does not have enough contraception\n* Changes of medication related to chronic diseases (diabetes, hypertension, dyslipidemia, etc.) within 3 months\n* Usage of dyslipidemia therapy other than statin","ALL","20 Years","80 Years",{"count":85,"type":86},105,"ESTIMATED","INTERVENTIONAL",[89],"PHASE4","This is a randomized controlled study to assess the effect of atorvastatin and omega 3 combination therapy compared with atorvastatin and ezetimibe combination therapy in Korean T2DM patients with asymptomatic atherosclerosis.",[92,93,94],"Dyslipidemias","Atherosclerosis","Diabetes Mellitus, Type 2","2026-05-02",{"date":97,"type":98},"2026-05-05","ACTUAL",{"date":100,"type":98},"2022-10-01",{"date":102,"type":86},"2026-12-31",{"name":5,"class":6},1]